Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) announced it will present a pooled analysis of data from three Phase 1 trials ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE